Silexion Therapeutics Corp SLXNW
Set alert
0.01 USD 0.00 +28.07%
As of Oct 30, 3:34 PM ET
0.0043 Day range 0.0092
0.0073 52-week range 0.0073
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.032
- Prev close
- 0.0057
- Mkt cap
- 3.20K
- Vol
- 17.05K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0043
- High
- 0.0092
- Forward P/E
- 0.00
- Beta
- -0.11
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-24.71 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.2×
FY 2020 5y median -0.2× FY 2025
P/S 0.0×
FY 2020 5y median 0.0× FY 2025
P/B 1.0×
FY 2020 5y median -0.1× FY 2025
P/FCF -0.2×
FY 2020 5y median -0.4× FY 2025
EV/EBITDA 0.2×
FY 2020 5y median -0.3× FY 2025
EV/Sales 0.0×
FY 2020 5y median 0.0× FY 2025
FCF Yield -424.2%
FY 2020 5y median -231.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2020 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2020 5y median 0.0% FY 2025
ROE -457.6%
FY 2020 5y median 30.1% FY 2025
ROIC 250.7%
FY 2020 5y median -49.2% FY 2025
ROA -165.1%
FY 2020 5y median -94.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2025
Operating Income 192.5%
FY 2020 FY 2025
EPS (diluted) 97.7%
FY 2020 FY 2025
Free Cash Flow -28.6%
FY 2020 FY 2025
Financial Health
Current Ratio 2.4×
FY 2020 5y median 2.3× FY 2025
Quick Ratio 2.4×
FY 2020 5y median 2.3× FY 2025
Debt / Equity 0.2×
FY 2020 5y median -0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2020 5y median 0.5× FY 2025
Interest Coverage 895×
FY 2020 5y median -45.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31